Float Short %

7.69

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

0.05

EPS Last/This Y

EPS This/Next Y

0.33

Price

52.03

Target Price

66.5

Analyst Recom

Performance Q

-1.68

Relative Volume

1.1

Beta

1.77

Ticker: VCEL

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	VCEL	57.33	0.14	0.09	1133
2025-01-24	VCEL	57.38	0.14	0.18	1154
2025-01-27	VCEL	59.71	0.14	0.60	1161
2025-01-28	VCEL	60.08	0.14	0.13	1160
2025-01-29	VCEL	59.01	0.14	999.99	1175
2025-01-30	VCEL	59.25	0.15	0.00	1177
2025-01-31	VCEL	58.49	0.15	0.07	1179
2025-02-03	VCEL	59.04	0.14	0.00	1244
2025-02-04	VCEL	58.9	0.13	2.86	1239
2025-02-05	VCEL	61.73	0.13	0.00	1242
2025-02-06	VCEL	59.62	0.13	0.00	1253
2025-02-07	VCEL	58.33	0.13	0.60	1272
2025-02-10	VCEL	58.66	0.12	0.18	1271
2025-02-11	VCEL	57.47	0.13	0.56	1274
2025-02-12	VCEL	56.06	0.13	0.18	1284
2025-02-13	VCEL	56.8	0.14	0.13	1301
2025-02-14	VCEL	57.1	0.14	0.00	1298
2025-02-18	VCEL	57.32	0.14	0.22	1296
2025-02-19	VCEL	57.8	0.14	0.00	1297
2025-02-20	VCEL	54.29	0.14	0.50	1298
2025-02-21	VCEL	52.06	0.14	0.25	1304
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	VCEL	57.42	26.9	-	0.14
2025-01-24	VCEL	57.37	26.9	-	0.14
2025-01-27	VCEL	59.77	26.9	-	0.14
2025-01-28	VCEL	60.05	26.9	-	0.14
2025-01-29	VCEL	58.99	26.9	-	0.14
2025-01-30	VCEL	59.25	30.8	-	0.14
2025-01-31	VCEL	58.45	30.8	-	0.14
2025-02-03	VCEL	59.06	30.8	-	0.14
2025-02-04	VCEL	59.43	30.8	-	0.14
2025-02-05	VCEL	61.78	30.8	-	0.14
2025-02-06	VCEL	59.60	30.8	-	0.14
2025-02-07	VCEL	58.39	30.8	-	0.14
2025-02-10	VCEL	58.65	30.8	-	0.14
2025-02-11	VCEL	57.56	30.8	-	0.14
2025-02-12	VCEL	56.04	30.8	-	0.14
2025-02-13	VCEL	56.81	30.8	-	0.14
2025-02-14	VCEL	57.09	30.8	-	0.14
2025-02-18	VCEL	57.24	30.8	-	0.14
2025-02-19	VCEL	57.78	30.8	-	0.14
2025-02-20	VCEL	54.25	30.8	-	0.14
2025-02-21	VCEL	52.03	30.8	-	0.14
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	VCEL	-31.56	0.23	7.59
2025-01-24	VCEL	-31.56	0.23	7.59
2025-01-27	VCEL	-31.56	0.16	7.59
2025-01-28	VCEL	-31.56	0.16	7.56
2025-01-29	VCEL	-31.56	0.16	7.56
2025-01-30	VCEL	-31.97	0.16	7.56
2025-01-31	VCEL	-31.97	0.16	7.56
2025-02-03	VCEL	-31.97	-0.86	7.56
2025-02-04	VCEL	-31.97	-0.86	7.56
2025-02-05	VCEL	-31.97	-0.86	7.56
2025-02-06	VCEL	-31.97	-0.86	7.56
2025-02-07	VCEL	-32.34	-0.86	7.56
2025-02-10	VCEL	-31.62	-1.18	7.64
2025-02-11	VCEL	-17.75	-1.18	7.64
2025-02-12	VCEL	-17.75	-1.18	7.76
2025-02-13	VCEL	-17.75	-1.18	7.76
2025-02-14	VCEL	-31.86	-1.18	7.68
2025-02-18	VCEL	-28.13	0.50	7.69
2025-02-19	VCEL	-27.49	0.50	7.69
2025-02-20	VCEL	-27.68	0.50	7.69
2025-02-21	VCEL	-27.68	0.50	7.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.02

Avg. EPS Est. Current Quarter

0.32

Avg. EPS Est. Next Quarter

0.03

Insider Transactions

-27.68

Institutional Transactions

0.5

Beta

1.77

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

24.5

Max Drawdown 5-Year %

-74

Target Price

66.5

P/E

832

Forward P/E

117.29

PEG

P/S

11.31

P/B

9.95

P/Free Cash Flow

EPS

0.06

Average EPS Est. Cur. Y

0.14

EPS Next Y. (Est.)

0.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.56

Relative Volume

1.1

Return on Equity vs Sector %

-17.9

Return on Equity vs Industry %

-2.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Vericel Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 314

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

stock quote shares VCEL – Vericel Corporation Stock Price stock today

news today VCEL – Vericel Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch VCEL – Vericel Corporation yahoo finance google finance

stock history VCEL – Vericel Corporation invest stock market

stock prices VCEL premarket after hours

ticker VCEL fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VCEL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y